“…We also evaluated in hypothalamus, liver, and BB concentrations of FA, triglyceride, total lipid, glucose, and glycogen (only in liver), as well as variables related to putative FA-sensing systems based on (1) FA metabolism, such as activities of fatty acid synthase (FAS), malonyl-CoA decarboxylase activity (MCD; only in liver), ATPcitrate lyase (ACLY; only in hypothalamus), and CPT-1, and mRNA abundance of acetyl-CoA carboxylase (ACC; only in hypothalamus), ACLY, CPT-1a (in BB), CPT-1b (in BB), CPT-1c (hypothalamus), and FAS; (2) binding to FAT/CD36 and further modulation of transcription factors, such as mRNA abundance of FAT/CD36, PPARa, SREBP1c, and liver X receptor a (LXRa); and (3) mitochondrial activity, such as mRNA abundance of mitochondrial uncoupling protein 2a (UCP2a), hydroxyacyl-CoA dehydrogenase (HOAD), inward rectifier K þ channel pore type 6.x-like (Kir6.x-like), and sulfonylurea receptor-like (SUR-like; only in liver). These variables have been previously reported to change in the same species in response to increased levels of OL or OCT [8][9][10][11][12][13][14][15][16].…”